Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes

ABSTRACT:

SUBMITTER: Singhal S 

PROVIDER: S-EPMC12621429 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature